Navigation Links
Express Diagnostics Welcomes New Controller
Date:10/24/2013

Blue Earth, MN (PRWEB) October 24, 2013

Express Diagnostics Int’l, Inc. (EDI) is pleased to welcome Dave Klabunde as controller. In the position, Klabunde will direct EDI’s finance department, as well as serve an advisory role in company-wide financial and business decisions.

Klabunde previously served as financial analyst/controller for Fairmont Orthopedics & Sports Medicine and, prior to that, as program-operations manager at Youth Services International, Inc. (YSI), a residential treatment facility for juveniles. While at YSI, Klabunde was involved in all aspects of the organization’s operations, including operational planning and direction of cross-functional departments, financial planning, and leading human resources information systems and information technology initiatives.

“We are very pleased to have Dave join our team as controller,” says Paul Johnson, CEO of Express Diagnostics. “His extensive background in business and financial planning, as well as his broad operations experience, will be a great asset in clarifying decision points as we progress as a company. Dave will be instrumental in helping management direct our tremendous growth.”

Klabunde started with EDI in early October and looks forward to ‘getting up to speed’ with the various tasks and departments he will be involved with as controller. “I like the business side of controller duties, because numbers don’t lie,” he says. “My role will be to look forward and around what’s going on to allow management to make decisions on the overall direction of the organization.”

Originally from Nebraska, Klabunde has lived in the Blue Earth, Minn., area since 1997. He and his wife, Karen, have three children: Ryanne, 15; Taylor and Matthew, both 8.

About Express Diagnostics Int’l, Inc.

Express Diagnostics Int’l manufactures and distributes DrugCheck® on-site urine and saliva screening devices for the detection of drugs of abuse, as well as a growing catalog of rapid alcohol screening and health diagnostics devices. With accuracy comparable to laboratory testing, Express Diagnostics onsite devices provide a variety of industries fast, cost-effective alternatives to higher-priced lab services. Learn more at drugcheck.com.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11262425.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
2. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
3. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
4. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
5. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
6. HemoShear Partners with Expression Analysis (EA) to Develop a Human Drug-Induced Vascular Response Database
7. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
8. Exon skipping to restore gene expression is promising therapeutic strategy for muscular dystrophy
9. Antigen Express AE37 Breast Cancer Vaccine Featured In "Micro-Cap Review" Interview
10. transOMIC technologies Releases Tagged ORF Clones for Protein Expression
11. Free Research Report on Dyax Corp., Ebix, Inc., 8x8, Inc., EnerSys and Express Scripts Holding Co.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont Pioneer ... that they have entered into a multiyear collaboration to identify and characterize novel ... additional tools for gene editing across all applications. , Under the terms of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Market with the addition of its newest module, US Hemostats & Sealants. , ... thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Rosalind™, the first-ever genomics analysis platform specifically designed for life science researchers ... honor of pioneering researcher Rosalind Franklin, who made a major contribution to ...
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
Breaking Biology Technology:
(Date:8/23/2017)... help is being enlisted in what,s thought to be the biggest study ... body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest study to date of ... goal is to help advance scientific knowledge of the role of these ... The Microbiome ...
(Date:7/20/2017)... DAL ) customers now can use fingerprints instead of their ... (DCA). ... launches biometrics to board aircraft at Reagan Washington National Airport ... Delta,s biometric boarding pass experience that launched in May at ... process to allow eligible Delta SkyMiles Members who are enrolled in CLEAR ...
(Date:6/23/2017)... ARMONK, N.Y. and ITHACA, N.Y. ... IBM ) and Cornell University, a leader in dairy ... combined with bioinformatics designed to help reduce the chances ... breaches. With the onset of this dairy project, Cornell ... the Consortium for Sequencing the Food Supply Chain, a ...
Breaking Biology News(10 mins):